The $40,000 Knee Replacement and the Hospital Monopoly Behind It

In Hickory, North Carolina, a knee replacement under a Blue Cross Blue Shield plan costs about $16,000. Drive an hour west to Asheville, and the same procedure at Mission Hospital under the same insurer runs roughly $40,000—more than double. That gap, drawn from newly available pricing data collected by startup Serif Health under a 2021 federal price transparency rule, illustrates a pervasive national pattern: when hospitals consolidate into systems with little local competition, they can demand prices dramatically higher than those at facilities without dominant market power.

The Serif Health figures, pulled from insurer-negotiated rates disclosed by hospitals, show that such disparity is not a regional quirk. In Melbourne, Florida, Holmes Regional Medical Center, part of the Health First system that dominates Brevard County, charges Cigna twice as much for a knee replacement as a hospital two hours away. In Colorado, Banner North Colorado Medical Center in Greeley—Weld County’s leading provider—bills a UnitedHealthcare patient $20,000 more than a Denver health system an hour to the south. Researchers have long suspected that the merger wave that began in the late 1990s and produced more than 1,000 hospital deals has been a primary driver of healthcare inflation. Now, with prices laid bare, the link between market power and higher charges is unmistakable.

The consequences ripple far beyond the operating room. When insurers pay inflated hospital bills, they pass the cost through to premiums. The full cost of an average employer-sponsored family plan crossed $27,000 in 2025, up from $21,000 only six years earlier, according to KFF. In Asheville, restaurateur Katie Button, who provides health coverage for about 100 employees, says she has no choice but to include Mission in her plan because it is the region’s only acute-care hospital. “We are where we are because we don’t have a choice of hospitals,” she says. The surcharge lands on every policyholder, sidelining the ability to shop around that patients like lactation consultant Marcelle Crago discovered: when Mission quoted her over $9,000 for meniscus surgery, she moved the procedure to an outpatient center and paid less than a third of that price.

Pricing Leverage, Policy Vacillation, and the Real Cost of Consolidation

How Hospital Mergers Created Bargaining Monsters

Advertisement

The mechanics are straightforward. When a health system commands a region, insurers cannot afford to exclude it from their networks, so the system extracts higher rates. The phenomenon is what health economist Zack Cooper of Yale calls “bargaining leverage.” His analysis shows that over the last quarter-century, hospital prices have risen faster than those in any other economic sector, with consolidation as a primary accelerant. The data collected by Serif Health, using the machine-readable files that hospitals must now post, confirms that gap: in Asheville, Mission’s negotiated prices sit at 334% of Medicare rates, while comparably-sized Catawba Valley Medical Center in Hickory comes in at 237%, against a state benchmark of 280%.

The Asheville Experiment: From Merger to HCA’s For-Profit Grab

Nowhere does the merger-to-monopoly pipeline appear more starkly than at Mission Hospital. Formed by the 1998 union of the two acute-care hospitals in Asheville, the system was initially shackled by state-imposed price and profit limits. Even then, research cited by the FTC shows it still managed substantial hikes. In 2015, Mission lobbied the legislature to abandon those restrictions. Three years later, HCA Healthcare—the country’s largest for-profit hospital operator—acquired the now-unregulated monopoly. “That put a prepackaged monopoly into the hands of the world’s largest for-profit hospital corporation,” says Mark Hall, a Wake Forest law professor who has chronicled the merger. The result is not just high prices but, as three “immediate jeopardy” findings by state inspectors since 2024 indicate, sometimes questionable care—a hallmark of markets where competition evaporates.

Policy Whiplash: Federal Antitrust Vacillation and State-Level Pushback

Advertisement

Antitrust enforcement has been inconsistent. From 2002 to 2020, the FTC intervened in only about 1% of hospital mergers. Last year, President Trump revoked a Biden-era directive that had urged aggressive merger challenges, but FTC Chairman Andrew Ferguson later called for a task force on healthcare deals that raise prices. Meanwhile, states are stepping in: Minnesota’s 2023 ban on anticompetitive healthcare mergers, California’s 90-day advance notice rule, and Oregon’s 2021 law letting the health department block hospital consolidations. Yet the big deals keep coming. Last year saw 46 hospital mergers, including five mega-deals over a billion dollars and a tie-up that welded 28 hospitals across Connecticut and New York. Kaufman Hall data suggests the consolidation engine remains in overdrive.

The Insurance Premium Pass-Through

Hospital charges are not isolated line items; they are the single largest driver of insurance premium growth, says a UnitedHealthcare statement. Employers in monopoly hospital markets like Asheville report that their group plan costs are structurally higher because the dominant system’s rates are unavoidable. The burden is especially heavy on small businesses and workers who must pay more for coverage or skip it altogether. A KFF poll this spring found that nearly two-thirds of U.S. adults worry about affording healthcare—a worry that hospital consolidation turns into a budget certainty.

What Employers, Patients, and Policymakers Can Do About Hospital Pricing Power

  • For Employers: Use claims data to identify the price variation that tools like the CMS transparency files now expose; consider reference-based pricing models that peg reimbursement to a fair benchmark, protecting the patient from the balance bill. Demand that insurers offer narrow-network plans excluding the highest-cost hospitals when safe alternatives exist, as Katie Button’s experience in Asheville shows that bargaining power rests on being the only option.
  • For Patients: For non-emergency procedures, shop around. Crago’s switch to an outpatient center cut her bill by two-thirds; many facilities offer cash-pay discounts if you ask upfront—Mission itself offered a 20% reduction to keep her on the books. Use your insurer’s cost estimator tool and cross-check with hospital price lists to see if a short drive can slash the out-of-pocket cost, as the Hickory-to-Asheville comparison demonstrates.
  • For Policymakers: Enforce the existing price transparency rule rigorously; the data revolution is moot if hospitals only post incomplete or unintelligible files. Adopt state oversight frameworks like Minnesota’s or Oregon’s that can block anticompetitive mergers before they inflate prices. Require merging parties to demonstrate concrete savings that outweigh the proven premium increases that follow consolidation, rather than accepting the hospital industry’s broad assertion that bigger means better.

Risk & Opportunity Assessment

Commercial RiskHighDominant hospital systems that rely on price-negotiation leverage face revenue erosion if the new transparency data sparks regulatory rate caps or employer-driven patient steering to lower-cost alternatives, as the knee-replacement price gaps demonstrate.
Competitive RiskMediumPrice visibility could redirect market share to outpatient surgery centers and competing hospitals in adjacent areas. Crago’s experience saved her two-thirds of Mission’s price; scaled across millions of procedures, this redirection threatens the volume that underpins monopoly pricing.
Regulatory RiskHighThe FTC’s new task force on healthcare mergers explicitly targets deals that raise prices. State-level laws in Minnesota, California, and Oregon show tightened oversight. The wide price disparities documented here strengthen the case for more muscular antitrust intervention.
Reputation RiskHighMission Hospital’s simultaneous high prices and CMS immediate-jeopardy findings create a toxic combination of cost and quality concerns. As more consumers see the numbers, the narrative of price-gouging—already documented in class-action lawsuits—can erode community trust and invite political backlash.
Technology DisruptionLowNo direct technology threat exists in this story; the disruption comes from price transparency platforms like Serif Health, which merely expose existing inefficiencies rather than replace the service. The risk is economic, not technological.
Commercial OpportunityHighThe data proving that identical procedures cost multiples more at monopoly hospitals creates a ready market for insurers that build narrow networks excluding the most expensive providers, for outpatient centers that can compete on price, and for price-comparison startups to embed in benefit plan design.